Literature DB >> 18351473

Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study.

C DiIorio1, F McCarty, K Resnicow, M McDonnell Holstad, J Soet, K Yeager, S M Sharma, D E Morisky, B Lundberg.   

Abstract

The primary aim of this study was to test an intervention to support antiretroviral medication adherence among primarily low-income men and women with HIV. The study was a randomized controlled trial (Get Busy Living) with participants assigned to treatment (Motivational Interviewing [MI]) and control groups. Participants were recruited from an HIV/AIDS clinic in Atlanta, Georgia, US. Of those referred to the study, 247 completed a baseline assessment and were enrolled with 125 randomized to the intervention group and 122 to the control group. Participants were patients beginning antiretroviral therapy or changing to a new drug regimen. The intervention consisted of five MI sessions delivered by registered nurses in individual counselling sessions. Participants were paid for each session attended. The intervention sought to build confidence, reduce ambivalence and increase motivation for ART medication-taking. Medication adherence was measured by the Medication Event Monitoring System (MEMS) from the time of screening until the final follow-up conducted approximately 12 months following the baseline assessment. Participants in the intervention condition showed a trend towards having a higher mean percent of prescribed doses taken and a greater percent of doses taken on schedule when compared to the control group during the months following the intervention period. This effect was noted beginning at about the eighth month of the study period and was maintained until the final study month. Although the finding was weaker for overall percent of prescribed doses taken, the results for the percent of doses taken on schedule suggests that the MI intervention may be a useful approach for addressing specific aspects of medication adherence, such as adherrence to a specified dosing schedule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351473      PMCID: PMC3103182          DOI: 10.1080/09540120701593489

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  18 in total

1.  Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.

Authors:  R M Ryan; E L Deci
Journal:  Am Psychol       Date:  2000-01

2.  A comparison study of multiple measures of adherence to HIV protease inhibitors.

Authors:  H Liu; C E Golin; L G Miller; R D Hays; C K Beck; S Sanandaji; J Christian; T Maldonado; D Duran; A H Kaplan; N S Wenger
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

Review 3.  Motivational interviewing for improving adherence to antiretroviral medications.

Authors:  Nina A Cooperman; Julia H Arnsten
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  Electronic monitoring: adherence assessment or intervention?

Authors:  Glenn J Wagner; Bonnie Ghosh-Dastidar
Journal:  HIV Clin Trials       Date:  2002 Jan-Feb

6.  Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study.

Authors:  Colleen DiIorio; Ken Resnicow; Marcia McDonnell; Johanna Soet; Frances McCarty; Katherine Yeager
Journal:  J Assoc Nurses AIDS Care       Date:  2003 Mar-Apr       Impact factor: 1.354

7.  Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.

Authors:  Glenn J Wagner
Journal:  AIDS Patient Care STDS       Date:  2002-12       Impact factor: 5.078

Review 8.  Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences.

Authors:  Jeannette R Ickovics; Christina S Meade
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

9.  A prospective study of predictors of adherence to combination antiretroviral medication.

Authors:  Carol E Golin; Honghu Liu; Ron D Hays; Loren G Miller; C Keith Beck; Jeanette Ickovics; Andrew H Kaplan; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

10.  Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.

Authors:  John Farley; Susan Hines; Amy Musk; Sherley Ferrus; Vicki Tepper
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

View more
  57 in total

1.  Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Jason R Williams; Heidi M Crane; Joseph J Eron; Elvin H Geng; Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2018-03

2.  Motivational groups support adherence to antiretroviral therapy and use of risk reduction behaviors in HIV positive Nigerian women: a pilot study.

Authors:  Marcia McDonnell Holstad; James E Essien; Ernest Ekong; Melinda Higgins; Ilya Teplinskiy; Modupe Falilatu Adewuyi
Journal:  Afr J Reprod Health       Date:  2012-09

3.  Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation.

Authors:  O Ojo-Fati; J L Thomas; R I Vogel; O Ogedegbe; G Jean-Louis; K S Okuyemi
Journal:  J Fam Med       Date:  2016-09-06

4.  Motivational Interviewing (MI) to Change Type 2DM Self Care Behaviors: A Nursing Intervention.

Authors:  Cheryl Dellasega; Robert Gabbay; Kendra Durdock; Nancy Martinez-King
Journal:  J Diabetes Nurs       Date:  2010

Review 5.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

6.  A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.

Authors:  Manel Pladevall; George Divine; Karen E Wells; Ken Resnicow; L Keoki Williams
Journal:  Diabetes Educ       Date:  2014-12-08       Impact factor: 2.140

7.  Does the quality of safetalk motivational interviewing counseling predict sexual behavior outcomes among people living with HIV?

Authors:  Catherine Grodensky; Carol Golin; Megha A Parikh; Rebecca Ochtera; Carlye Kincaid; Jennifer Groves; Laura Widman; Chirayath Suchindran; Camille McGirt; Kemi Amola; Steven Bradley-Bull
Journal:  Patient Educ Couns       Date:  2016-08-13

8.  Training Primary Care Physicians to Employ Self-Efficacy-Enhancing Interviewing Techniques: Randomized Controlled Trial of a Standardized Patient Intervention.

Authors:  Anthony Jerant; Richard L Kravitz; Daniel Tancredi; Debora A Paterniti; Lynda White; Lynn Baker-Nauman; Dionne Evans-Dean; Chloe Villarreal; Lori Ried; Andrew Hudnut; Peter Franks
Journal:  J Gen Intern Med       Date:  2016-03-08       Impact factor: 5.128

Review 9.  Informing the dosing of interventions in randomized trials.

Authors:  Corrine I Voils; Yunkyung Chang; Jamie Crandell; Jennifer Leeman; Margarete Sandelowski; Matthew L Maciejewski
Journal:  Contemp Clin Trials       Date:  2012-07-27       Impact factor: 2.226

10.  Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.

Authors:  Matthias Kalder; Volker Ziller; Ioannis Kyvernitakis; Dana Knöll; Olaf Hars; Peyman Hadji
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.